| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 18, 2020 |
Chief Commercial Officer
Trans History: 5
|
Chief Commercial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 120,000 | -- | 120,000 |
| Mar 01, 2019 |
Chief Commercial Officer
Trans History: 5
|
Chief Commercial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- | 60,000 |
| Oct 01, 2018 |
Chief Commercial Officer
Trans History: 5
|
Chief Commercial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 64,640 | -- | 64,640 |
| Aug 21, 2018 |
Chief Commercial Officer
Trans History: 5
|
Chief Commercial Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 21, 2018 |
Chief Commercial Officer
Trans History: 5
|
Chief Commercial Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Sep 20, 2023 |
Chief Financial Officer
Trans History: 2
|
Chief Financial Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Sep 18, 2023 |
Chief Financial Officer
Trans History: 2
|
Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 106,000 | -- | 106,000 |
| May 12, 2023 |
Chief Financial Officer
Trans History: 14
|
Chief Financial Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 50,000 | $0.67 | 281,373 |
| Feb 15, 2023 |
Chief Financial Officer
Trans History: 14
|
Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 105,000 | -- | 231,373 |
| Feb 15, 2023 |
Chief Financial Officer
Trans History: 14
|
Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 490,000 | -- | 490,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.